Visionflex Group Limited · ASX:VFX

Visionflex — Investor Presentation (June 2024)

39 slides from Visionflex's investor presentation, Jun 26, 2024

  1. Slide 1: Visionflex Group Investor Presentation

    Visionflex Group ASX:VFX Investor Presentation

  2. Slide 2: The mission

    The mission Empowering health practitioners globally with cutting Zedge technologies to elevate patient outcomes. Room! Pro! GEIS® vision. For personal use on proprietary har e and software connect a range of third-party al devices to empo practitioners to deliver world class virtual care. Visionfle

  3. Slide 3: For personal use only

    • • • For personal use only • • • • • • • • • • • • • • •

  4. Slide 4: For personal use only

    For personal use only • • • • • • • • • • • • • •

  5. Slide 5: Board and Executive Management Team

    Board and Executive Management Team EXECUTIVE LEADERSHIP TEAM Joshua Mundey Michael Kafrouni C) CHIEF EXECUTIVE OFFICER CHIEF OPERATING OFFICER * Former Co-Founder & Chief Growth Officer at * 18+ years’ experience as a senior executive for multinational Credabl, growing company to 100 staff and $2b

  6. Slide 6: Visionflex market drivers in place for growth

    Visionflex Group Visionflex market drivers in place for growth

  7. Slide 7: For personal use only

    For personal use only 600 500 400 300 200 100 0 2023 2030

  8. Slide 8: For personal use only

    For personal use only • • • • • • • • • • • • • • •

  9. Slide 9: Visionflex products & Business Model

    Visionflex Group Visionflex products & Business Model

  10. Slide 10: Hardware

    Hardware Visionflex hardware enables health practitioners to virtually conduct medical examinations with confidence and serves as a foundational step for establishing long term software subscriptions. nly. Uso GEIS® Camera and peripheral devices integrated with Visionflex software, to deliver clinic

  11. Slide 11: Proprietary Software (Virtual Care Platform)

    Proprietary Software (Virtual Care Platform) A virtual healthcare platform allowing practitioners to virtually examine, diagnose, monitor and treat patients. a> Cc ee CProEx Software vision. erform collaborative, clinical, evidence-based consultations between clinicians Auser-friendly video conferen

  12. Slide 12: Revenue Model

    Revenue Model Y.. Offering Key Product / Services rsonal use onl Revenue Streams UPFRONT / ONE-OFF ey RECURRING REVENUE $5k — $30k per unit depending on solution 4 $ f ~$5k per annum for annual software license cp margin pe 60-65% GP margin | | 90-95% GP margin For Repeat Revenue Visionflex Group BU

  13. Slide 13: Industry verticals & case studies

    Visionflex Group Industry verticals & case studies

  14. Slide 14: Strong momentum in key verticals

    Strong momentum in key verticals =phn. phn phn Cc s ° — fo) () wsprimary Yn" =) © PRIMARY HEALTH NETWORKS o} ” (ab) & hese = et e lok 5 Re ane bat i NeW LOCAL HEALTH DISTRICTS Visionflex Group Bapteare @BlueCare & benetas Live life your way i) tas Souther Cross Care Uniting (Tas) Ine. AGED CARE # IN

  15. Slide 15: For personal use only

    For personal use only • • • • • • • • • • • • • • • • • • • • • •

  16. Slide 16: For personal use only

    • • • For personal use only • • • • • • • • • •

  17. Slide 17: Total Addressable Markets (TAM)

    Total Addressable Markets (TAM) Building on its strong momentum, Visionflex Shas the potential to significantly grow its market share across key vertical industries personal use onl ) Calculated based on the number of licenses already S= sold by Visionflexin an industry divided by the number of serv

  18. Slide 18: Total Addressable Markets (TAM) continues

    Total Addressable Markets (TAM) continues ildi isionfl CORRECTIONAL FACILITIES Building on its strong momentum, Visionflex TAM** $2,777,040 as the potential to significantly grow its market share across key vertical industries. 0% 13.79% (=) &) mSites mServices 100% mAlready held by Visionflex* m= A

  19. Slide 19: International expansion

    International expansion eecees only ° Visionflex products have generated over $1M in revenue in the past from Americas, Europe and Asia. Untapped growth opportunities through strategic partnerships. Initial focus on accelerating growth in the Americas, DIRECT Europe and Asia. VERTICAL Australia & NZ

  20. Slide 20: Financial overview

    Visionflex Group Financial overview

  21. Slide 21: Revenue - Visionflex division

    Revenue -— Visionflex division w w & o a 5 N G o = oc a ° a ° ° For personal use only $m REVENUE MIX BY STREAM FOR THE VISIONFLEX BUSINESS DIVISION TH FY23 2H FY23 = Non Recurring Revenue (Hardware) (+) 2H FY24 result is the unaudited trajectory. Visionflex Group TH FY24 2H FY24(*) ™Annual Recurring

  22. Slide 22: Profit & Loss - consolidated entity

    Profit & Loss — consolidated entity Strong Visionflex revenue growth while reducing the overall cost base to drive near-term EBIDTA profitability. > Prioritising profitable 30 JUNE Y/E ($m) FY23 Yael”) operations Yeonles 10 1s $3 37 2s Ov @ _ Visionflex FY24 revenue up at least WDregacy Business Uni

  23. Slide 23: Outlook

    Visionflex Group Outlook

  24. Slide 24: For personal use only

    For personal use only • • • • • • • • • • • • • • •

  25. Slide 25: Capital Raising

    Visionflex Group Capital Raising

  26. Slide 26: Financial recapitalisation well supported by major shareholders and Board

    Financial recapitalisation well supported by major shareholders and Board For personal use only • • • • •

  27. Slide 27: For personal use only

    For personal use only • • • • • • • •

  28. Slide 28: For personal use only

    For personal use only • • • • • • • • • • • • •

  29. Slide 29: Capital Raise - Indicative Timetable

    Capital Raise — Indicative Timetable! (Trading halt and announcement of Placement and Underwritten Non-Renounceable Entitlement Offer Monday 24 June 2024 ie) wrorerment of Placement and Entitlement Offer and Trading Halt is lifted and trading resumes on an “ex-entitlement” basis Wednesday 26 June 20

  30. Slide 30: Appendix

    Visionflex Group Appendix

  31. Slide 31: Capital structure

    Capital structure COMPANY PROFILE AS AT 21 JUNE 2024 * shares on Issue 1,416,991,197 share Price $0.005 Ovranet capitalisation $7.1M Doptions on issue 1,320,000 Performance Rights on Issue 87,880,082 =——=Converting Notes (Principal only) $6.825M Clndrawn Facilities $1.575M Ocash Balance (@ 31 Mar) $

  32. Slide 32: Important notices

    Important notices This presentation (Presentation) has been prepared by Vislonflex Group Limited ACN 138 897 $33 [ASX-VFX) (Company) and is dated 24 June2024, Acceptance ‘The informotonin this Presentation remains subjctt change without neice, By accepting this Prosenttion, you agree tobe bound by t

  33. Slide 33: Key Risks

    Key Risks This section discusses some of the key risks associated with any investment in Visionflex Group Limited (VFX), which may affect the value of VFX shares. The risks set out below are not necessarily sted in order of importance and do not constitute an exhaustive list of all risks involved wi

  34. Slide 34: Key Risks (continued)

    Key Risks (continued) Material customer contracts | use onl Cybersecurity persona itellectual property and Software development For Supply chain risk Visionflex Group Visionflex has entered into various material contracts for its products and the accompanying software and support for each cart for e

  35. Slide 35: Key Risks (continued)

    Key Risks (continued) Foreign exchange use onl Regulatory and compliance ‘eliance on key personnel For personal Visionflex Group Changes in exchange rates can impact the value of revenue, expenses, assets, liabilities when those components are denominated in foreign currencies through either transac

  36. Slide 36: Key Risks (continued)

    Key Risks (continued) ©Dependence on key suppliers g g Oo © 3 Competition ersonal use For p Visionflex Group Visionfiex currently has strategic business relationships with suppliers that it relies upon for key parts of its business activities. Some of these relationships are in countries which may b

  37. Slide 37: Key Risks (continued)

    Key Risks (continued) Technology Input Prices Litigation ersonal_use onl Changing consumer preferences For p Change in law and healthcare policy Visionflex Group The technology sector is characterised by rapid change. New and disruptive technologies can place competitive pressures on existing compan

  38. Slide 38: Key Risks (continued)

    Key Risks (continued) ec General economic factors such as interest rates, exchange rates, inflation, business and consumer confident and general market factors may have an adverse impact on Visionflex Group (VFX) performance, prospects or the value of its assets. The market price of VFX shares will

  39. Slide 39: Visionflex Group Limited contact

    Visionflex Group Visionflex Group Limited Unit 1, 8 Prosperity Parade, Warriewood NSW 2102 VISIONFLEX.COM.AU Joshua Mundey CHIEF EXECUTIVE OFFICER E: jmundey@visionflex.com

Visionflex Group — Investor Presentation (June 2024) on 6ix